These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27749053)

  • 1. Sulfamide as Zinc Binding Motif in Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa).
    Halland N; Czech J; Czechtizky W; Evers A; Follmann M; Kohlmann M; Schreuder HA; Kallus C
    J Med Chem; 2016 Oct; 59(20):9567-9573. PubMed ID: 27749053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) from Natural Product Anabaenopeptin.
    Halland N; Brönstrup M; Czech J; Czechtizky W; Evers A; Follmann M; Kohlmann M; Schiell M; Kurz M; Schreuder HA; Kallus C
    J Med Chem; 2015 Jun; 58(11):4839-44. PubMed ID: 25990761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphinanes and Azaphosphinanes as Potent and Selective Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor (TAFIa).
    Schaffner AP; Sansilvestri-Morel P; Despaux N; Ruano E; Persigand T; Rupin A; Mennecier P; Vallez MO; Raimbaud E; Desos P; Gloanec P
    J Med Chem; 2021 Apr; 64(7):3897-3910. PubMed ID: 33764059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the selective inhibition of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) by a selenium-containing inhibitor with chloro-aminopyridine as a basic group.
    Itoh T; Yoshimoto N; Hirano Y; Yamamoto K
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2256-2260. PubMed ID: 29859906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of conformationally restricted inhibitors of active thrombin activatable fibrinolysis inhibitor (TAFIa).
    Brink M; Dahlén A; Olsson T; Polla M; Svensson T
    Bioorg Med Chem; 2014 Apr; 22(7):2261-8. PubMed ID: 24588961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation, Co-Crystallization and Structure-Based Characterization of Anabaenopeptins as Highly Potent Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa).
    Schreuder H; Liesum A; Lönze P; Stump H; Hoffmann H; Schiell M; Kurz M; Toti L; Bauer A; Kallus C; Klemke-Jahn C; Czech J; Kramer D; Enke H; Niedermeyer THJ; Morrison V; Kumar V; Brönstrup M
    Sci Rep; 2016 Sep; 6():32958. PubMed ID: 27604544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flat SAR of P3-methylsulphonamide based small molecule legumain inhibitors.
    Ness KA; Eddie SL; Burton S; Harrison T; Mullan P; Williams R
    Bioorg Med Chem Lett; 2016 Jan; 26(2):413-416. PubMed ID: 26653614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of potent & selective inhibitors of activated thrombin-activatable fibrinolysis inhibitor for the treatment of thrombosis.
    Bunnage ME; Blagg J; Steele J; Owen DR; Allerton C; McElroy AB; Miller D; Ringer T; Butcher K; Beaumont K; Evans K; Gray AJ; Holland SJ; Feeder N; Moore RS; Brown DG
    J Med Chem; 2007 Nov; 50(24):6095-103. PubMed ID: 17990866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor.
    Mori M; Moraca F; Deodato D; Ferraris DM; Selchow P; Sander P; Rizzi M; Botta M
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2508-11. PubMed ID: 24767848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationally designed sulfamides as glutamate carboxypeptidase II inhibitors.
    Choy CJ; Fulton MD; Davis AL; Hopkins M; Choi JK; Anderson MO; Berkman CE
    Chem Biol Drug Des; 2013 Nov; 82(5):612-9. PubMed ID: 23773397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for inhibition of carboxypeptidase B by selenium-containing inhibitor: selenium coordinates to zinc in enzyme.
    Yoshimoto N; Itoh T; Inaba Y; Ishii H; Yamamoto K
    J Med Chem; 2013 Oct; 56(19):7527-35. PubMed ID: 24010887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures of potent thiol-based inhibitors bound to carboxypeptidase B.
    Adler M; Bryant J; Buckman B; Islam I; Larsen B; Finster S; Kent L; May K; Mohan R; Yuan S; Whitlow M
    Biochemistry; 2005 Jul; 44(26):9339-47. PubMed ID: 15982000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygenated analogues of UK-396082 as inhibitors of activated thrombin activatable fibrinolysis inhibitor.
    Owen DR; Bull DJ; Bunnage ME; Glossop MS; Maguire RJ; Strang RS
    Bioorg Med Chem Lett; 2010 Jan; 20(1):92-6. PubMed ID: 19954973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa).
    Islam I; Bryant J; May K; Mohan R; Yuan S; Kent L; Morser J; Zhao L; Vergona R; White K; Adler M; Whitlow M; Buckman BO
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1349-54. PubMed ID: 17189688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization versus inhibition of TAFIa by competitive inhibitors in vitro.
    Walker JB; Hughes B; James I; Haddock P; Kluft C; Bajzar L
    J Biol Chem; 2003 Mar; 278(11):8913-21. PubMed ID: 12643276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) - part I: pharmacological characterization.
    Wang YX; Zhao L; Nagashima M; Vincelette J; Sukovich D; Li W; Subramanyam B; Yuan S; Emayan K; Islam I; Hrvatin P; Bryant J; Light DR; Vergona R; Morser J; Buckman BO
    Thromb Haemost; 2007 Jan; 97(1):45-53. PubMed ID: 17200770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of imidazole acetic acid inhibitors of activated thrombin-activatable fibrinolysis inhibitor as novel antithrombotics.
    Barrow JC; Nantermet PG; Stauffer SR; Ngo PL; Steinbeiser MA; Mao SS; Carroll SS; Bailey C; Colussi D; Bosserman M; Burlein C; Cook JJ; Sitko G; Tiller PR; Miller-Stein CM; Rose M; McMasters DR; Vacca JP; Selnick HG
    J Med Chem; 2003 Dec; 46(25):5294-7. PubMed ID: 14640538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of covalent active site inhibitors of dengue virus protease.
    Koh-Stenta X; Joy J; Wang SF; Kwek PZ; Wee JL; Wan KF; Gayen S; Chen AS; Kang C; Lee MA; Poulsen A; Vasudevan SG; Hill J; Nacro K
    Drug Des Devel Ther; 2015; 9():6389-99. PubMed ID: 26677315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAFIa inhibitors in the treatment of thrombosis.
    Bunnage ME; Owen DR
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):480-6. PubMed ID: 18600565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and characterization of a selenium-containing inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa), a zinc-containing metalloprotease.
    Yoshimoto N; Sasaki T; Sugimoto K; Ishii H; Yamamoto K
    J Med Chem; 2012 Sep; 55(17):7696-705. PubMed ID: 22891675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.